Compare $PHIO vs $TOVX | Chartloom

Compare

$PHIO vs $TOVX

Phio Pharmaceuticals Corp · Theriva Biologics Inc

PHIO

Phio Pharmaceuticals Corp

TOVX

Theriva Biologics Inc

Compare $PHIO vs $TOVX

Comparing Phio Pharmaceuticals Corp and Theriva Biologics Inc

PHIOPhio Pharmaceuticals Corp

TOVXTheriva Biologics Inc

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

TOVXTheriva Biologics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-16.5%

52W performance

-51.8%

FCF yield

-128.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PHIO

TOVX

Detailed metrics comparison

PHIO

Phio Pharmaceuticals Corp

TOVX

Theriva Biologics Inc

Market Cap

PHIO$11M

TOVX$10M

Enterprise Value

PHIO$-2M

TOVX$275K

Price

PHIO$0.98

TOVX$0.22

P/E Ratio

PHION/A

TOVXN/A

P/S Ratio

PHIO81.74x

TOVX33.19x

EV/Sales

PHIO-11.08x

TOVX0.92x

EV/EBITDA

PHIO0.00x

TOVX0.00x

P/B Ratio

PHIO0.91x

TOVX0.85x

P/FCF Ratio

PHION/A

TOVXN/A

EV/FCF

PHIO0.13x

TOVX-0.02x

PEG Ratio

PHION/A

TOVXN/A

Forward P/E (NTM)

PHION/A

TOVXN/A

Forward P/S (NTM)

PHION/A

TOVXN/A

Revenue (TTM)

PHIO$0

TOVX$300K

Revenue Growth (YoY)

PHION/A

TOVXN/A

Forward Rev Growth

PHIO0.0%

TOVX20375.2%

Gross Margin (TTM)

PHIO0.0%

TOVX71.5%

Operating Margin (TTM)

PHIO0.0%

TOVX0.0%

EBITDA Margin (TTM)

PHIO0.0%

TOVX-3940.7%

Net Margin (TTM)

PHIO0.0%

TOVX-4376.0%

FCF Margin (TTM)

PHION/A

TOVX-4254.7%

Net Income (TTM)

PHIO$-13M

TOVX$-13M

FCF (TTM)

PHIO$-12M

TOVX$-13M

EPS (TTM)

PHIO-$1.11

TOVX-$0.29

ROE (TTM)

PHIO-8741.0%

TOVX-9349.0%

ROA (TTM)

PHIO-7976.0%

TOVX-3269.0%

ROIC (TTM)

PHIO-8741.0%

TOVX-8231.0%

Cash

PHIO$13M

TOVX$11M

Debt

PHIO$0

TOVX$2M

Net Cash/Debt

PHIO$13M

TOVX$10M

Current Ratio (TTM)

PHIO8.39x

TOVX1.13x

Quick Ratio (TTM)

PHIO7.62x

TOVX1.09x

Debt/Equity (TTM)

PHIO0.00x

TOVX0.14x

Debt/Assets (TTM)

PHIO0.0%

TOVX0.0%

Interest Coverage (TTM)

PHION/A

TOVXN/A

Net Debt/EBITDA (TTM)

PHIO0.00x

TOVX0.00x

Beta

PHIO0.90

TOVX1.25

52W Performance

PHIO-59.6%

TOVX-51.8%

YTD Performance

PHIO-10.2%

TOVX-16.5%

% from 52W High

PHIO-76.6%

TOVX-74.8%

% from 52W Low

PHIO20.8%

TOVX35.6%

Asset Turnover (TTM)

PHIO0.02x

TOVX0.01x

FCF Yield (TTM)

PHIO-107.3%

TOVX-128.2%

Earnings Yield (TTM)

PHIO-113.5%

TOVX-131.8%

Dividend Yield (TTM)

PHION/A

TOVXN/A

Rule of 40

PHIO0.0

TOVX-4,254.7

EV/GP/RG

PHION/A

TOVX0.00

Ticker research

View PHIO research View TOVX research

Metric	PHIO Phio Pharmaceuticals Corp	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$11M	$10M
Enterprise Value	$-2M	$275K
Price	$0.98	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	81.74x	33.19x
EV/Sales	-11.08x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.13x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$300K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	20375.2%
Profitability
Gross Margin (TTM)	0.0%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3940.7%
Net Margin (TTM)	0.0%	-4376.0%
FCF Margin (TTM)	N/A	-4254.7%
Net Income (TTM)	$-13M	$-13M
FCF (TTM)	$-12M	$-13M
EPS (TTM)	-$1.11	-$0.29
ROE (TTM)	-8741.0%	-9349.0%
ROA (TTM)	-7976.0%	-3269.0%
ROIC (TTM)	-8741.0%	-8231.0%
Financial Health
Cash	$13M	$11M
Debt	$0	$2M
Net Cash/Debt	$13M	$10M
Current Ratio (TTM)	8.39x	1.13x
Quick Ratio (TTM)	7.62x	1.09x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.90	1.25
52W Performance	-59.6%	-51.8%
YTD Performance	-10.2%	-16.5%
% from 52W High	-76.6%	-74.8%
% from 52W Low	20.8%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.01x
FCF Yield (TTM)	-107.3%	-128.2%
Earnings Yield (TTM)	-113.5%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View PHIO research	View TOVX research

Valuation

P/S Ratio

TOVX

33.19x

PHIO

81.74x

EV/FCF

TOVX

-0.02x

PHIO

0.13x

Growth & revenue

Forward Revenue Growth

TOVX

20375.2%

PHIO

0.0%

Profitability & performance

Gross Margin

TOVX

71.5%

PHIO

0.0%

ROE

PHIO

-8741.0%

TOVX

-9349.0%

FCF Yield %

PHIO

-107.3%

TOVX

-128.2%

52-Week Performance

TOVX

-51.8%

PHIO

-59.6%

Detailed metrics comparison

PHIO

Phio Pharmaceuticals Corp

TOVX

Theriva Biologics Inc

Market Cap

PHIO$11M

TOVX$10M

Enterprise Value

PHIO$-2M

TOVX$275K

Price

PHIO$0.98

TOVX$0.22

P/E Ratio

PHION/A

TOVXN/A

P/S Ratio

PHIO81.74x

TOVX33.19x

EV/Sales

PHIO-11.08x

TOVX0.92x

EV/EBITDA

PHIO0.00x

TOVX0.00x

P/B Ratio

PHIO0.91x

TOVX0.85x

P/FCF Ratio

PHION/A

TOVXN/A

EV/FCF

PHIO0.13x

TOVX-0.02x

PEG Ratio

PHION/A

TOVXN/A

Forward P/E (NTM)

PHION/A

TOVXN/A

Forward P/S (NTM)

PHION/A

TOVXN/A

Revenue (TTM)

PHIO$0

TOVX$300K

Revenue Growth (YoY)

PHION/A

TOVXN/A

Forward Rev Growth

PHIO0.0%

TOVX20375.2%

Gross Margin (TTM)

PHIO0.0%

TOVX71.5%

Operating Margin (TTM)

PHIO0.0%

TOVX0.0%

EBITDA Margin (TTM)

PHIO0.0%

TOVX-3940.7%

Net Margin (TTM)

PHIO0.0%

TOVX-4376.0%

FCF Margin (TTM)

PHION/A

TOVX-4254.7%

Net Income (TTM)

PHIO$-13M

TOVX$-13M

FCF (TTM)

PHIO$-12M

TOVX$-13M

EPS (TTM)

PHIO-$1.11

TOVX-$0.29

ROE (TTM)

PHIO-8741.0%

TOVX-9349.0%

ROA (TTM)

PHIO-7976.0%

TOVX-3269.0%

ROIC (TTM)

PHIO-8741.0%

TOVX-8231.0%

Cash

PHIO$13M

TOVX$11M

Debt

PHIO$0

TOVX$2M

Net Cash/Debt

PHIO$13M

TOVX$10M

Current Ratio (TTM)

PHIO8.39x

TOVX1.13x

Quick Ratio (TTM)

PHIO7.62x

TOVX1.09x

Debt/Equity (TTM)

PHIO0.00x

TOVX0.14x

Debt/Assets (TTM)

PHIO0.0%

TOVX0.0%

Interest Coverage (TTM)

PHION/A

TOVXN/A

Net Debt/EBITDA (TTM)

PHIO0.00x

TOVX0.00x

Beta

PHIO0.90

TOVX1.25

52W Performance

PHIO-59.6%

TOVX-51.8%

YTD Performance

PHIO-10.2%

TOVX-16.5%

% from 52W High

PHIO-76.6%

TOVX-74.8%

% from 52W Low

PHIO20.8%

TOVX35.6%

Asset Turnover (TTM)

PHIO0.02x

TOVX0.01x

FCF Yield (TTM)

PHIO-107.3%

TOVX-128.2%

Earnings Yield (TTM)

PHIO-113.5%

TOVX-131.8%

Dividend Yield (TTM)

PHION/A

TOVXN/A

Rule of 40

PHIO0.0

TOVX-4,254.7

EV/GP/RG

PHION/A

TOVX0.00

Ticker research

View PHIO research View TOVX research

Metric	PHIO Phio Pharmaceuticals Corp	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$11M	$10M
Enterprise Value	$-2M	$275K
Price	$0.98	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	81.74x	33.19x
EV/Sales	-11.08x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.13x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$300K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	20375.2%
Profitability
Gross Margin (TTM)	0.0%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3940.7%
Net Margin (TTM)	0.0%	-4376.0%
FCF Margin (TTM)	N/A	-4254.7%
Net Income (TTM)	$-13M	$-13M
FCF (TTM)	$-12M	$-13M
EPS (TTM)	-$1.11	-$0.29
ROE (TTM)	-8741.0%	-9349.0%
ROA (TTM)	-7976.0%	-3269.0%
ROIC (TTM)	-8741.0%	-8231.0%
Financial Health
Cash	$13M	$11M
Debt	$0	$2M
Net Cash/Debt	$13M	$10M
Current Ratio (TTM)	8.39x	1.13x
Quick Ratio (TTM)	7.62x	1.09x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.90	1.25
52W Performance	-59.6%	-51.8%
YTD Performance	-10.2%	-16.5%
% from 52W High	-76.6%	-74.8%
% from 52W Low	20.8%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.01x
FCF Yield (TTM)	-107.3%	-128.2%
Earnings Yield (TTM)	-113.5%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View PHIO research	View TOVX research